By Kaplan–Meier analysis on pancreatic cancer, the level of each gene is linked to survival probability, with high expression for E2F1, PRMT5 and cortactin/CTTN linked to poor survival (Fig. 5e). This evidence concerns the gene PRMT5 and pancreatic neoplasm.